Kardigan, Inc. Common Stock KARD · Stock Open Kardigan, Inc. Common Stock in new tab
Analyst price targets
Recent rating changes, newest first
Kardigan, Inc. Common Stock Analysis (KARD)
Is Kardigan, Inc. Common Stock a good investment? Kardigan, Inc. Common Stock (KARD) is currently trading at 12.80 USD. Market analysts have a consensus price target of 39.29 USD. This suggests a potential upside from current levels.
Earnings Schedule: Kardigan, Inc. Common Stock is expected to release its next earnings report on Nov. 10, 2026. The market consensus estimate for Forward EPS is -4.17.
Investor FAQ
Does Kardigan, Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Kardigan, Inc. Common Stock?
Kardigan, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 10, 2026. The company currently has a trailing EPS of -10.65.
Company Profile
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio's cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.
Community Discussion